H1 2021 interims: still on track
Destiny's interim H1 2021 financial results were an upbeat and extensive update on the clinical...
Read moreAUM growth ahead of forecasts and segment
On 31 August 2021, two months into financial Q4 and 11 months into FY21, AUM reached £38.0bn,...
Read more
FY21 interim results: a strong rebound
For the six months to 30 June 2021 Mpac Group reported a strong recovery in both orders, +69%YoY,...
Read more
Confident AGM And Trading Update
RUA Life Sciences’ AGM statement and trading update demonstrated good progress across its...
Read moreFull occupancy and strong portfolio outlook
The interims from RAV confirm momentum building behind portfolio values as lower vacancy rates...
Read moreAnother year of good growth delivered
UPGS’s pre-close FY2021 trading statement confirmed a strong end to the financial year with most...
Read moreContinued strong execution & positive outlook
Given the tightening UK jobs market with vacancies back to pre-covid levels, it’s no wonder...
Read moreRobust outcome to a year of great change
Marshall of Cambridge performed strongly in what proved to be a challenging year. Profitability...
Read moreGroup hits strategic targets, our forecasts rise
The headline news associated with the pre-close H1 update is that strong trading at Crestchic, plus...
Read moreCentricus combination declared Effective by SEC
Following unanimous approval by both companies’ Boards, on 2 August Arqit announced that that the...
Read moreRegister to be first
Get research on the companies that interest you straight to your inbox
